PharmaTimes Magazine - Home
CANCER - Bizarro cancer world. PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
2024 - PharmaTimes
Latest jobs from #PharmaRole. Territory Sales Manager - North London & East Anglia. Chief Business Officer. Territory Sales Manager - North London & East Anglia. Primary Care Immunisation Facilitator - Home based. National Account Manager - Anti-infectives - Midlands/Yorkshire. Brand Manager - Fertility Supplements - Watford.
Microbiotica begins human trials for ulcerative colitis treatment
1 day ago · Microbiotica, a clinical-stage biopharma company, has announced the dosing of the first patient in its Phase 1b First-in-Human trial, COMPOSER-1, for MB310 in ulcerative colitis (UC) patients. This international trial aims to recruit up to 30 adult patients across the UK, Austria, Bulgaria, Poland, and Spain.
PharmaTimes | in-depth news, features and insights for the ...
3 days ago · Line of duty. Oct 24, 2024. Multiple uses for brands are changing pharma’s data needs.
PharmaTimes Magazine - Issues
Aug 26, 2024 · January/February 2024 - PharmaTimes. We peruse the priorities for 2024 – innovation, partnerships and a focus on unmet clinical needs. Meanwhile, we focus on the healthcare horoscope of politics, tech, data, public health and the rise of the patient. Hop on for the ride as we ask how the NHS will be reconstructed, if the success in hepatitis ...
PharmaTimes Magazine - Articles
Oct 22, 2024 · PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Pharmaceuticals in 2022 - PharmaTimes
Dec 7, 2021 · Published in PharmaTimes magazine - December 2021. The pharma industry has been pivotal during the pandemic and this focus looks set to continue into 2022. The coronavirus pandemic has not only boosted many pharmaceutical companies’ revenues, it has also bolstered their reputations. The value of pharma innovation is undoubted, after COVID-19 ...
PharmaTimes - June 2024
This issue is about the shaping, delivery and future of clinical trials – the exciting dawn of a new era for how therapies reach the marketplace. We cover the influence of digital, the radical shift in trial design and, above all, the need to incorporate patients at every stage. We’ve also got a review of our International Clinical Researcher of the Year bash – an unforgettable 25th ...
PharmaTimes - June 2021
This month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our industry. Our insightful front cover article delves into the key regulatory considerations on both sides of the Atlantic for starting cell and gene therapy trials (p26), while others look at the rise of genetic sequencing (p30) and 2021 trends in global trials (p20).
PharmaTimes International Clinical Researcher of the Year
International Clinical Researcher of the Year 2025. Celebrating excellence in clinical research for more than 2 decades. After an impressive 2024 competition the 2025 competition has now been launched! Offering once-again a renowned set of challenges in various categories designed to test, develop, and reward clinical researchers.